BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

526783

DRAGARWQ

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

DR.AGARWALS EYE HOSPITAL LTD. Share Price Update

As of the latest trading session, DR.AGARWALS EYE HOSPITAL LTD. share price is currently at ₹ 4501.1, which is up by ₹ 48.25 from its previous closing. Today, the stock has fluctuated between ₹ 4400.00 and ₹ 4525.00. Over the past year, DR.AGARWALS EYE HOSPITAL LTD. has achieved a return of 14.28 %. In the last month alone, the return has been 0.55 %. Read More...

Investment Returns

Over 1 Month 0.55% Over 3 Months 2.99% Over 6 Months 14.59% Over 1 Year 14.28%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

DR.AGARWALS EYE HOSPITAL LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    2,115.50

  • P/E Ratio (TTM)

    36.21

  • Beta

    0.75

  • Book Value / share

    445.97

  • Return on equity

    34.28%

  • EPS (TTM)

    122.98

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    17.26

info icon alternate text

DR.AGARWALS EYE HOSPITAL LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 116.92
Operating Expense 94.53
Net Profit 17.26
Net Profit Margin (%) 14.76
Earnings Per Share (EPS) 36.72
EBITDA 37.93
Effective Tax Rate (%) 25.57
Particulars MAR 2025 (Values in Cr)
Revenue 99.83
Operating Expense 81.33
Net Profit 15.99
Net Profit Margin (%) 16.01
Earnings Per Share (EPS) 34.02
EBITDA 31.69
Effective Tax Rate (%) 14.03
Particulars DEC 2024 (Values in Cr)
Revenue 95.11
Operating Expense 83.36
Net Profit 10.40
Net Profit Margin (%) 10.93
Earnings Per Share (EPS) 22.13
EBITDA 27.93
Effective Tax Rate (%) 26.03
Particulars SEP 2024 (Values in Cr)
Revenue 102.19
Operating Expense 85.34
Net Profit 14.15
Net Profit Margin (%) 13.84
Earnings Per Share (EPS) 30.11
EBITDA 32.16
Effective Tax Rate (%) 26.03
Particulars JUN 2024 (Values in Cr)
Revenue 100.02
Operating Expense 81.51
Net Profit 14.11
Net Profit Margin (%) 14.10
Earnings Per Share (EPS) 30.02
EBITDA 31.81
Effective Tax Rate (%) 25.38
Particulars MAR 2025 (Values in Cr)
Revenue 397.15
Operating Expense 331.54
Net Profit 54.65
Net Profit Margin (%) 13.76
Earnings Per Share (EPS) 116.28
EBITDA 123.59
Effective Tax Rate (%) 22.70
Particulars MAR 2024 (Values in Cr)
Revenue 319.30
Operating Expense 262.02
Net Profit 46.36
Net Profit Margin (%) 14.51
Earnings Per Share (EPS) 98.64
EBITDA 96.03
Effective Tax Rate (%) 25.52
Particulars MAR 2023 (Values in Cr)
Revenue 268.10
Operating Expense 220.25
Net Profit 36.92
Net Profit Margin (%) 13.77
Earnings Per Share (EPS) 78.55
EBITDA 76.44
Effective Tax Rate (%) 25.26
Particulars MAR 2022 (Values in Cr)
Revenue 201.21
Operating Expense 170.16
Net Profit 24.10
Net Profit Margin (%) 11.97
Earnings Per Share (EPS) 51.29
EBITDA 58.93
Effective Tax Rate (%) 25.41
Particulars MAR 2021 (Values in Cr)
Revenue 139.81
Operating Expense 134.89
Net Profit -1.44
Net Profit Margin (%) -1.02
Earnings Per Share (EPS) -3.06
EBITDA 31.18
Effective Tax Rate (%) 125.13
Particulars MAR 2024 (Values in Cr)
Book Value / Share 334.36
ROE % 34.28
ROCE % 17.89
Total Debt to Total Equity 1.85
EBITDA Margin 30.43
Particulars MAR 2023 (Values in Cr)
Book Value / Share 241.15
ROE % 38.56
ROCE % 18.22
Total Debt to Total Equity 2.22
EBITDA Margin 28.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 166.32
ROE % 36.29
ROCE % 19.63
Total Debt to Total Equity 1.96
EBITDA Margin 29.77
Particulars MAR 2021 (Values in Cr)
Book Value / Share 116.30
ROE % -2.60
ROCE % 10.36
Total Debt to Total Equity 1.15
EBITDA Margin 22.74
Particulars MAR 2020 (Values in Cr)
Book Value / Share 119.36
ROE % 26.91
ROCE % 29.26
Total Debt to Total Equity 0.82
EBITDA Margin 28.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 33.74
Total Assets 495.76
Total Liabilities 495.76
Total Equity 157.15
Share Outstanding 4700000
Price to Book Ratio 9.28
Return on Assets (%) 9.35
Return on Capital (%) 22.24
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 28.10
Total Assets 389.94
Total Liabilities 389.94
Total Equity 113.34
Share Outstanding 4700000
Price to Book Ratio 3.80
Return on Assets (%) 9.46
Return on Capital (%) 23.49
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 28.80
Total Assets 314.01
Total Liabilities 314.01
Total Equity 78.17
Share Outstanding 4700000
Price to Book Ratio 4.39
Return on Assets (%) 7.67
Return on Capital (%) 21.89
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 22.19
Total Assets 155.23
Total Liabilities 155.23
Total Equity 54.66
Share Outstanding 4700000
Price to Book Ratio 2.69
Return on Assets (%) -0.92
Return on Capital (%) -1.89
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.88
Total Assets 140.55
Total Liabilities 140.55
Total Equity 56.10
Share Outstanding 4700000
Price to Book Ratio 1.60
Return on Assets (%) 9.73
Return on Capital (%) 19.73
Particulars MAR 2024 (Values in Cr)
Net Income 62.25
Cash from Operations 103.38
Cash from Investing -70.04
Cash from Financing -14.23
Net change in Cash 5.50
Free Cash Flow 174.69
Particulars MAR 2023 (Values in Cr)
Net Income 49.40
Cash from Operations 81.14
Cash from Investing -70.61
Cash from Financing 0.26
Net change in Cash -0.73
Free Cash Flow 151.48
Particulars MAR 2022 (Values in Cr)
Net Income 24.10
Cash from Operations 65.61
Cash from Investing -46.28
Cash from Financing -3.81
Net change in Cash 6.59
Free Cash Flow 112.34
Particulars MAR 2021 (Values in Cr)
Net Income -1.43
Cash from Operations 37.19
Cash from Investing -10.96
Cash from Financing -7.59
Net change in Cash 15.30
Free Cash Flow 48.38
Particulars MAR 2020 (Values in Cr)
Net Income 13.68
Cash from Operations 45.36
Cash from Investing -16.67
Cash from Financing -19.93
Net change in Cash 2.00
Free Cash Flow 62.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7676.95 70.15 13.45 110382.76 6002.15 / 7981.20
FORTIS MALAR HOSPITALS LIMITED 67.36 27.38 4.18 126.24 51.01 / 98.70
SHREE PACETRONIX LTD. 167.30 57.69 4.36 60.22 61.11 / 187.00
TRANSGENE BIOTEK LTD. 3.99 0.00 3.01 30.23 3.22 / 8.88
VIMTA LABS LIMITED 656.00 48.02 8.51 2919.57 254.43 / 728.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7676.95 81.68 12.63 110382.76 6002.15 / 7981.20
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 37.98 0.00 -15.01 28.37 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6299.05 31.26 6.34 6891.16 4777.15 / 6525.00

DR.AGARWALS EYE HOSPITAL LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
4501.10 1.08 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 4607.60
  • 26 Days 4555.70
  • 10 Days 4631.30
  • 50 Days 4489.20
  • 12 Days 4623.10
  • 100 Days 4463.70
  • 20 Days 4581.60
  • 200 Days 4442.40
4435.93 PIVOT

First Support

4366.92

First Resistance

4521.87

Second Support

4280.98

Second Resistance

4590.88

Third Support

4211.97

Third Resistance

4676.82

RSI

46.94

ADX

45.73

MACD

67.38

Williams % R

-81.79

Commodity Channel Index (CCI)

-43.84

Date

2025-08-29

Week

5689.00

Same Day

3924.00

Month

2123.00

1 Year

0.76

3 Year

0.68

Over 1 Month

0.55%

down

Over 1 Year

14.28%

down

Over 3 Months

2.99%

down

Over 3 Years

77.22%

down

Over 6 Months

14.59%

down

Over 5 Years

77.88%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

DR.AGARWALS EYE HOSPITAL LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

DR.AGARWALS EYE HOSPITAL LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
08 Nov 2024 2.5 Interim 08 Nov 2024 Equity shares
19 Aug 2024 2.5 Final 20 Aug 2024 Equity shares
31 Oct 2023 2.5 Interim 31 Oct 2023 Equity shares
14 Sep 2023 3.0 Final 15 Sep 2023 Equity shares
06 Sep 2022 3.0 Final 08 Sep 2022 Equity shares
16 Sep 2019 1.5 Final 18 Sep 2019 Equity shares
21 Aug 2018 1.2 Final 24 Aug 2018 Equity shares
14 Aug 2017 1.5 Final 17 Aug 2017 Equity shares
12 Aug 2016 0.8 Final 17 Aug 2016 Equity shares
01 Sep 2015 1.2 Final 03 Sep 2015 Equity shares
28 Aug 2014 1.2 Final 02 Sep 2014 Equity shares
02 Aug 2013 1.2 Final 06 Aug 2013 Equity shares
11 Aug 2011 1.2 Final 16 Aug 2011 Equity shares
13 Aug 2010 0.8 Final 17 Aug 2010 Equity shares
13 Sep 2007 1.5 Final 15 Sep 2007 Equity shares
12 Sep 2005 0.0 Final 14 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

DR.AGARWALS EYE HOSPITAL LTD. Share Price

Founded in 1957, Dr. Agarwal's Eye Hospital Limited was incorporated on April 22, 1994. The Hospital is a leading chain of eye hospitals with predominant presence in Tamil Nadu. Under the able leadership of Dr Amar Agarwal, the Company has been a pioneer and leader in the Indian Ophthalmology market with an established market position, healthy brand recall in the eye care segment. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. It has presence in multiple locations in Tamil Nadu, Kerala and Rajasthan.

Till 30 Sep.'94 the eye care facility was provided by the family through various partnership firms owned by the family members. Since Oct.'94, the entire hospital business is carried on by the company. As such, it has the distinct advantage of capitalising on the reputation built by the Agarwals over a period of 37 years and aim at further growth by carrying out immediate expansion.

In 1995-96, the company commenced commercial production of pharmaceutical products in a limited way.

During 1996-97, it installed Lasik Excimer Laser which is of its only kind in India and the company has been constantly striving to update the surgical techniques by adopting innovative methods and by employing the latest equipments both for Surgery and Research.

During 2004, the Hospital started their Jaipur branch. It opened a Medical Enclave at Nungambakkam, Chennai and a Franchisee Centre at Thiruvanmyur, Chennai as Referral Centres of the Hospital. The Hospital carried out eye transplant operations. Tele-ophthalmic service was started by the Hospital during 2005. 14 new hospitals started their operations during the year 2008 in various parts of Chennai city and Tamil Nadu and Andhra Pradesh.

The Company relocated Salem branch during the financial year 2020-21. In FY 2022, it added a branch in Kallakurichi. It had 3 centres across the core markets as pilot projects - Gowriwakkam, Ambur, and Valliyur. In FY22, the Hospital initiated the process of establishing a new centre on Cathedral Road.

During the FY 2023, the Company had strengthened its presence in Southern Tamil Nadu by opening a branch in Nagercoil, and entered the Kerala market with a state-of-the-art branch in Cochin. The Company opened 3 vision centres in Chengalpattu, Gudiyattam, and Sankarankovil. As at March 31, 2023, the Company is operating in 31 locations and has one central store. Dr. Agarwal's Health Care Limited is the holding Company as at 31 March 2023.

Parent organization Indian Private
NSE symbol [-]
Founded 1994
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Dr Agarwals Eye Hospital Ltd?

Answer Field

Dr Agarwals Eye Hospital Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 4,501.10 as on Sep 02 2025 03:29 PM.

What is the Market Cap of Dr Agarwals Eye Hospital Ltd Share?

Answer Field

The market cap of Dr Agarwals Eye Hospital Ltd for NSE ₹ 0.00 & for BSE ₹ 2,115.50 as on Sep 02 2025 03:29 PM.

What is the 52 Week High and Low of Dr Agarwals Eye Hospital Ltd?

Answer Field

The 52 Week High and Low of Dr Agarwals Eye Hospital Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 7,300.00 and ₹ 3,500.00.

What is 1 year return for Dr Agarwals Eye Hospital Ltd?

Answer Field

The 1 year returns on the stock has been 14.28%.

What is the P/E Ratio of Dr Agarwals Eye Hospital Ltd Share?

Answer Field

As on Sep 02 2025 03:29 PM the price-to-earnings (PE) ratio for Dr Agarwals Eye Hospital Ltd share is 36.21.

What is the PB ratio of Dr Agarwals Eye Hospital Ltd Share?

Answer Field

As on Sep 02 2025 03:29 PM, the price-to-book (PB) ratio for Dr Agarwals Eye Hospital Ltd share is 445.97.

How to Buy Dr Agarwals Eye Hospital Ltd Share?

Answer Field

You can trade in Dr Agarwals Eye Hospital Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Dr Agarwals Eye Hospital Ltd Share on Bajaj Broking App?

Answer Field

To buy Dr Agarwals Eye Hospital Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Dr Agarwals Eye Hospital Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91